Shuta Tsuboi Selected Research

Shuta Tsuboi Research Topics

23	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2011
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2014
14	Acute Coronary Syndrome 01/2023 - 12/2011
7	Myocardial Infarction 10/2018 - 02/2014
5	Chronic Renal Insufficiency 09/2017 - 07/2015
4	Death (Near-Death Experience) 05/2021 - 01/2013
3	ST Elevation Myocardial Infarction 02/2024 - 01/2023
3	Inflammation (Inflammations) 01/2019 - 01/2011
3	Thrombosis (Thrombus) 01/2018 - 10/2015
2	Hemorrhage 12/2016 - 08/2015
2	Stroke (Strokes) 12/2016 - 01/2016
2	Stable Angina 11/2014 - 01/2013
1	Cardiogenic Shock 02/2024
1	Left Ventricular Dysfunction 01/2019
1	Malnutrition (Nutritional Deficiencies) 11/2017
1	Diabetes Mellitus 12/2016
1	Hyperglycemia 10/2016
1	Coronary Disease (Coronary Heart Disease) 09/2016
1	Renal Insufficiency (Renal Failure) 09/2016
1	Hypercholesterolemia 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2013

13	omega-Chloroacetophenone (Mace)IBA 10/2018 - 01/2014
6	C-Reactive ProteinIBA 01/2019 - 01/2013
5	Lipoprotein(a)IBA 01/2022 - 02/2016
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2015
3	Serum AlbuminIBA 11/2017 - 08/2017
3	oxidized low density lipoproteinIBA 12/2016 - 10/2015
2	AlbuminsIBA 09/2017 - 08/2017
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2016 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 01/2013
2	LDL CholesterolIBA 01/2016 - 01/2014
2	HDL CholesterolIBA 10/2015 - 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2018
1	CholesterolIBA 11/2017
1	Warfarin (Coumadin)FDA LinkGeneric 12/2016
1	1,5-anhydroglucitolIBA 10/2016
1	MetalsIBA 09/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	Everolimus FDA Link 10/2015
1	HDL LipoproteinsIBA 10/2015
1	LipidsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2014
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 12/2011
1	candesartanIBA 01/2011
1	Sirolimus (Rapamycin)FDA Link 01/2011

28	Percutaneous Coronary Intervention 02/2024 - 01/2013
5	Stents 09/2016 - 01/2011
4	Drug-Eluting Stents 12/2016 - 07/2015
4	Therapeutics 12/2016 - 01/2011
1	Catheters 01/2018
1	Dual Anti-Platelet Therapy 12/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2016
1	Secondary Prevention 01/2016